跳至主要内容
临床试验/ISRCTN13262303
ISRCTN13262303已完成4 期

Enamel matrix derivatives in periodontal regenerative surgery modulates cytokine profiles: A randomised controlled clinical trial

Regional Committees for Medical and Health Research Ethics (REK)0 个研究点目标入组 15 人开始时间: 2016年2月22日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged between 25 and 75 years
  • 2. Non-smoking
  • 3. No use of antibiotics over the previous 6 months prior to treatment
  • 4. The presence of one pair of interproximal sites with probing pocket depth (PPD) of 6 mm or more, horizontal and/or vertical bone loss as demonstrated by the probing measurement and radiographic assessments following the initial phase of periodontal treatment
  • 5. Experimental teeth must either have a vital pulp or, if subjected to root canal treatment, be asymptomatic, and without technical remarks
  • 6. Prior to the start of the trial, the patients will give informed consent

排除标准

  • 1. Patients with a systemic condition like diabetes mellitus, cancer, HIV, disorders that compromise wound healing, chronic high dose steroid therapy, bone metabolic disease, radiation or immune-suppressive therapy
  • 2. Patients with acute infectious lesions in the area of intended therapy

研究者

发起方
Regional Committees for Medical and Health Research Ethics (REK)

相似试验